Annual EBIT
-$30.94 M
+$445.60 K+1.42%
December 31, 2023
Summary
- As of February 10, 2025, DARE annual earnings before interest & taxes is -$30.94 million, with the most recent change of +$445.60 thousand (+1.42%) on December 31, 2023.
- During the last 3 years, DARE annual EBIT has fallen by -$3.54 million (-12.91%).
- DARE annual EBIT is now -4806.42% below its all-time high of -$630.60 thousand, reached on December 31, 2016.
Performance
DARE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$4.68 M
+$2.68 M+36.39%
September 30, 2024
Summary
- As of February 10, 2025, DARE quarterly earnings before interest & taxes is -$4.68 million, with the most recent change of +$2.68 million (+36.39%) on September 30, 2024.
- Over the past year, DARE quarterly EBIT has increased by +$490.20 thousand (+9.48%).
- DARE quarterly EBIT is now -1318.14% below its all-time high of $384.30 thousand, reached on June 30, 2022.
Performance
DARE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$23.23 M
+$3.72 M+13.79%
September 30, 2024
Summary
- As of February 10, 2025, DARE TTM earnings before interest & taxes is -$23.23 million, with the most recent change of +$3.72 million (+13.79%) on September 30, 2024.
- Over the past year, DARE TTM EBIT has increased by +$7.71 million (+24.90%).
- DARE TTM EBIT is now -2473.92% below its all-time high of -$902.70 thousand, reached on June 30, 2017.
Performance
DARE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DARE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.4% | +9.5% | +24.9% |
| 3 y3 years | -12.9% | +44.1% | +25.9% |
| 5 y5 years | -164.6% | +44.1% | +25.9% |
DARE EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.8% | -1318.1% | +71.2% | at high | +44.7% |
| 5 y | 5-year | -115.7% | +20.8% | -1318.1% | +71.2% | -62.0% | +44.7% |
| alltime | all time | -4806.4% | +20.8% | -1318.1% | +71.2% | -2473.9% | +46.2% |
Dare Bioscience EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.68 M(-36.4%) | -$23.23 M(-13.8%) |
| Jun 2024 | - | -$7.36 M(+22.2%) | -$26.95 M(-5.7%) |
| Mar 2024 | - | -$6.02 M(+16.5%) | -$28.58 M(-7.6%) |
| Dec 2023 | -$30.94 M(-1.4%) | -$5.17 M(-38.4%) | -$30.94 M(-26.3%) |
| Sep 2023 | - | -$8.40 M(-6.6%) | -$42.00 M(+3.1%) |
| Jun 2023 | - | -$8.99 M(+7.2%) | -$40.74 M(+29.9%) |
| Mar 2023 | - | -$8.38 M(-48.4%) | -$31.37 M(-0.1%) |
| Dec 2022 | -$31.39 M(-19.7%) | -$16.23 M(+127.4%) | -$31.39 M(+27.1%) |
| Sep 2022 | - | -$7.14 M(-1957.6%) | -$24.70 M(-18.3%) |
| Jun 2022 | - | $384.30 K(-104.6%) | -$30.23 M(-24.0%) |
| Mar 2022 | - | -$8.40 M(-12.0%) | -$39.78 M(+1.8%) |
| Dec 2021 | -$39.07 M(+42.6%) | -$9.54 M(-24.7%) | -$39.07 M(+2.9%) |
| Sep 2021 | - | -$12.67 M(+38.3%) | -$37.97 M(+15.5%) |
| Jun 2021 | - | -$9.16 M(+19.1%) | -$32.88 M(+6.6%) |
| Mar 2021 | - | -$7.69 M(-8.9%) | -$30.84 M(+12.6%) |
| Dec 2020 | -$27.40 M(+91.0%) | -$8.44 M(+11.3%) | -$27.40 M(+20.1%) |
| Sep 2020 | - | -$7.58 M(+6.4%) | -$22.82 M(+22.3%) |
| Jun 2020 | - | -$7.13 M(+67.5%) | -$18.66 M(+20.3%) |
| Mar 2020 | - | -$4.25 M(+10.2%) | -$15.52 M(+8.2%) |
| Dec 2019 | -$14.34 M(+22.7%) | -$3.86 M(+12.9%) | -$14.34 M(+6.7%) |
| Sep 2019 | - | -$3.42 M(-14.2%) | -$13.44 M(+6.3%) |
| Jun 2019 | - | -$3.98 M(+29.2%) | -$12.65 M(+2.9%) |
| Mar 2019 | - | -$3.08 M(+4.2%) | -$12.29 M(+5.1%) |
| Dec 2018 | -$11.69 M | -$2.96 M(+12.9%) | -$11.69 M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$2.62 M(-27.7%) | -$10.38 M(+14.2%) |
| Jun 2018 | - | -$3.62 M(+45.6%) | -$9.10 M(+52.9%) |
| Mar 2018 | - | -$2.49 M(+51.1%) | -$5.95 M(+61.3%) |
| Dec 2017 | -$3.69 M(+485.1%) | -$1.65 M(+23.6%) | -$3.69 M(+65.4%) |
| Sep 2017 | - | -$1.33 M(+178.0%) | -$2.23 M(+147.0%) |
| Jun 2017 | - | -$479.60 K(+109.9%) | -$902.70 K(-91.6%) |
| Mar 2017 | - | -$228.50 K(+21.2%) | -$10.69 M(-54.2%) |
| Dec 2016 | -$630.60 K(-98.3%) | -$188.60 K(+3043.3%) | -$23.34 M(-29.6%) |
| Sep 2016 | - | -$6000.00(-99.9%) | -$33.17 M(-23.2%) |
| Jun 2016 | - | -$10.26 M(-20.3%) | -$43.20 M(+2.1%) |
| Mar 2016 | - | -$12.88 M(+28.5%) | -$42.33 M(+13.9%) |
| Dec 2015 | -$37.16 M(+67.0%) | -$10.02 M(-0.2%) | -$37.16 M(+7.9%) |
| Sep 2015 | - | -$10.04 M(+6.9%) | -$34.45 M(+15.7%) |
| Jun 2015 | - | -$9.39 M(+21.9%) | -$29.77 M(+8.2%) |
| Mar 2015 | - | -$7.71 M(+5.5%) | -$27.51 M(+23.6%) |
| Dec 2014 | -$22.26 M(+42.2%) | -$7.30 M(+36.1%) | -$22.26 M(+23.6%) |
| Sep 2014 | - | -$5.37 M(-24.8%) | -$18.00 M(+16.5%) |
| Jun 2014 | - | -$7.13 M(+190.9%) | -$15.46 M(+19.9%) |
| Mar 2014 | - | -$2.45 M(-19.6%) | -$12.89 M(-17.7%) |
| Dec 2013 | -$15.66 M(-27.3%) | -$3.05 M(+8.2%) | -$15.66 M(+24.2%) |
| Sep 2013 | - | -$2.82 M(-38.3%) | -$12.61 M(+28.8%) |
| Jun 2013 | - | -$4.57 M(-12.5%) | -$9.79 M(+87.5%) |
| Mar 2013 | - | -$5.22 M | -$5.22 M |
| Dec 2012 | -$21.53 M | - | - |
FAQ
- What is Dare Bioscience annual earnings before interest & taxes?
- What is the all time high annual EBIT for Dare Bioscience?
- What is Dare Bioscience annual EBIT year-on-year change?
- What is Dare Bioscience quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Dare Bioscience?
- What is Dare Bioscience quarterly EBIT year-on-year change?
- What is Dare Bioscience TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Dare Bioscience?
- What is Dare Bioscience TTM EBIT year-on-year change?
What is Dare Bioscience annual earnings before interest & taxes?
The current annual EBIT of DARE is -$30.94 M
What is the all time high annual EBIT for Dare Bioscience?
Dare Bioscience all-time high annual earnings before interest & taxes is -$630.60 K
What is Dare Bioscience annual EBIT year-on-year change?
Over the past year, DARE annual earnings before interest & taxes has changed by +$445.60 K (+1.42%)
What is Dare Bioscience quarterly earnings before interest & taxes?
The current quarterly EBIT of DARE is -$4.68 M
What is the all time high quarterly EBIT for Dare Bioscience?
Dare Bioscience all-time high quarterly earnings before interest & taxes is $384.30 K
What is Dare Bioscience quarterly EBIT year-on-year change?
Over the past year, DARE quarterly earnings before interest & taxes has changed by +$490.20 K (+9.48%)
What is Dare Bioscience TTM earnings before interest & taxes?
The current TTM EBIT of DARE is -$23.23 M
What is the all time high TTM EBIT for Dare Bioscience?
Dare Bioscience all-time high TTM earnings before interest & taxes is -$902.70 K
What is Dare Bioscience TTM EBIT year-on-year change?
Over the past year, DARE TTM earnings before interest & taxes has changed by +$7.71 M (+24.90%)